Thomas Meyer

11.2k total citations · 2 hit papers
137 papers, 7.9k citations indexed

About

Thomas Meyer is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Thomas Meyer has authored 137 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 50 papers in Oncology and 22 papers in Organic Chemistry. Recurrent topics in Thomas Meyer's work include HER2/EGFR in Cancer Research (11 papers), Chronic Myeloid Leukemia Treatments (11 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). Thomas Meyer is often cited by papers focused on HER2/EGFR in Cancer Research (11 papers), Chronic Myeloid Leukemia Treatments (11 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). Thomas Meyer collaborates with scholars based in Switzerland, Germany and United States. Thomas Meyer's co-authors include Helmut Mett, Elisabeth Buchdunger, Doriano Fabbro, Nicholas Lydon, J. Zimmermann, Pascal Furet, Paul W. Manley, Ann Depicker, Marcel Müller and Peter Traxler and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Thomas Meyer

136 papers receiving 7.7k citations

Hit Papers

Inhibition of the Abl pro... 1996 2026 2006 2016 1996 2014 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thomas Meyer 3.7k 2.2k 1.5k 1.2k 961 137 7.9k
Aviv Gazit 5.3k 1.4× 3.3k 1.5× 1.0k 0.7× 1.1k 0.9× 920 1.0× 99 9.7k
Tilman M. Hackeng 3.5k 1.0× 1.1k 0.5× 2.9k 1.9× 1.2k 1.0× 871 0.9× 213 9.8k
Mark Lynch 3.5k 0.9× 2.6k 1.2× 642 0.4× 552 0.5× 301 0.3× 90 7.7k
Delong Liu 3.9k 1.1× 3.9k 1.8× 1.3k 0.9× 444 0.4× 1.3k 1.4× 189 9.1k
Kees Nooter 3.9k 1.1× 5.4k 2.5× 953 0.6× 428 0.3× 556 0.6× 149 9.1k
Iduna Fichtner 3.9k 1.1× 2.9k 1.3× 424 0.3× 930 0.8× 442 0.5× 242 8.1k
Lubor Borsig 3.3k 0.9× 2.1k 1.0× 892 0.6× 497 0.4× 312 0.3× 99 7.1k
William P. Tong 3.6k 1.0× 2.1k 1.0× 483 0.3× 649 0.5× 276 0.3× 110 6.6k
Gÿorgý Kéri 3.5k 0.9× 1.7k 0.8× 488 0.3× 592 0.5× 357 0.4× 162 6.1k
Robert M. Scarborough 2.3k 0.6× 571 0.3× 1.7k 1.1× 811 0.7× 506 0.5× 96 6.4k

Countries citing papers authored by Thomas Meyer

Since Specialization
Citations

This map shows the geographic impact of Thomas Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Meyer more than expected).

Fields of papers citing papers by Thomas Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Meyer. The network helps show where Thomas Meyer may publish in the future.

Co-authorship network of co-authors of Thomas Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Meyer. A scholar is included among the top collaborators of Thomas Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Meyer. Thomas Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sieg, Holger, Claudia Kästner, Benjamin Krause, et al.. (2017). Impact of an Artificial Digestion Procedure on Aluminum-Containing Nanomaterials. Langmuir. 33(40). 10726–10735. 40 indexed citations
2.
Lichtenstein, Dajana, Thomas Meyer, Linda Böhmert, et al.. (2017). Dosimetric Quantification of Coating-Related Uptake of Silver Nanoparticles. Langmuir. 33(45). 13087–13097. 15 indexed citations
3.
Lorite, I., Yogesh Kumar, P. Esquinazi, et al.. (2016). Photo-enhanced magnetization in Fe-doped ZnO nanowires. Applied Physics Letters. 109(1). 4 indexed citations
4.
Huster, Daniel, Thomas Meyer, Jörg Nikolaus, et al.. (2016). Cholesterol's Aliphatic Side Chain Structure Modulates Membrane Properties. Biophysical Journal. 110(3). 84a–84a.
5.
Meyer, Thomas, Bram Laukens, Jonah Nolf, et al.. (2015). Comparison of VHH‐Fc antibody production in Arabidopsis thaliana,Nicotiana benthamiana and Pichia pastoris. Plant Biotechnology Journal. 13(7). 938–947. 21 indexed citations
6.
Milles, Sigrid, Thomas Meyer, Holger A. Scheidt, et al.. (2013). Organization of fluorescent cholesterol analogs in lipid bilayers — Lessons from cyclodextrin extraction. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1828(8). 1822–1828. 34 indexed citations
7.
Buck, Sylvie De, Vikram Virdi, Thomas Meyer, et al.. (2012). Production of Camel-Like Antibodies in Plants. Methods in molecular biology. 911. 305–324. 19 indexed citations
8.
Meyer, Thomas, et al.. (2009). Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities. International Journal of Hyperthermia. 26(1). 16–20. 17 indexed citations
9.
Manley, Paul W., Josef Brüggen, Doriano Fabbro, Georg Martiny‐Baron, & Thomas Meyer. (2007). Extended kinase profiling of the Bcr-Abl inhibitor nilotinib. Cancer Research. 67. 3249–3249. 9 indexed citations
10.
Manley, Paul W., Juergen Mestan, Thomas Meyer, & Doriano Fabbro. (2004). An ELISA for PDGFR phosphorylation: Comparison of effects of STI571 on cellular Bcr-Abl, c-Kit and PDGFR-β protein kinases. Cancer Research. 64. 345–346. 1 indexed citations
11.
Traxler, Peter, Peter R. Allegrini, Ralf Brandt, et al.. (2004). AEE788. Cancer Research. 64(14). 4931–4941. 268 indexed citations
12.
Garcı́a-Echeverrı́a, Carlos, Mark Pearson, Andreas Marti, et al.. (2004). In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell. 5(3). 231–239. 447 indexed citations
13.
Meyer, Thomas, et al.. (2002). The surgeon as a cost factor. Cost analysis exemplified by surgical treatment of rectal carcinoma. Chirurg. 73(2). 167. 3 indexed citations
14.
Lansiaux, Amélie, Doriano Fabbro, Thomas Meyer, François Hamy, & Christian Bailly. (1999). Le PKC 412. Bulletin du Cancer. 86(7). 614–617. 1 indexed citations
15.
Meggio, Flavio, Arianna Donella Deana, Maria Ruzzene, et al.. (1995). Different Susceptibility of Protein Kinases to Staurosporine Inhibition. European Journal of Biochemistry. 234(1). 317–322. 242 indexed citations
16.
Fredenhagen, Andreas, Helmut Mett, Thomas Meyer, et al.. (1995). Protein Tyrosine Kinase and Protein Kinase C Inhibition by Fungal Anthraquinones Related to Emodin.. The Journal of Antibiotics. 48(11). 1355–1358. 27 indexed citations
17.
Schmidt, Martin, Burkhard Kröger, Elard Jacob, et al.. (1994). Molecular characterization of human and bovine endothelin converting enzyme (ECE‐1). FEBS Letters. 356(2-3). 238–243. 162 indexed citations
18.
McGlynn, Elaine, Janis Liebetanz, J M Wood, et al.. (1992). Expression and partial characterization of rat protein kinase C‐δ and protein kinase C‐ξ in insect cells using recombinant baculovirus. Journal of Cellular Biochemistry. 49(3). 239–250. 66 indexed citations
19.
Meyer, Thomas, et al.. (1986). Antagonism of Interferon Induction in Spleen and Adherent Peritoneal Cells of Mice by the Lipophilic Antiviral Muramyl Peptide MTP-PE. Journal of Interferon Research. 6(3). 183–188. 5 indexed citations
20.
Meyer, Thomas, et al.. (1968). Bifid sternum. Journal of Thoracic and Cardiovascular Surgery. 55(5). 758–760. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026